Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.
Schmitz S, Hamoir M, Reychler H, Magremanne M, Weynand B, Lhommel R, Hanin FX, Duprez T, Michoux N, Rommel D, Lonneux M, Cappoen N, Gillain A, Machiels JP. Schmitz S, et al. Among authors: michoux n. Ann Oncol. 2013 Sep;24(9):2261-6. doi: 10.1093/annonc/mdt180. Epub 2013 May 23. Ann Oncol. 2013. PMID: 23704200 Free article. Clinical Trial.
MRI for response assessment in metastatic bone disease.
Lecouvet FE, Larbi A, Pasoglou V, Omoumi P, Tombal B, Michoux N, Malghem J, Lhommel R, Vande Berg BC. Lecouvet FE, et al. Among authors: michoux n. Eur Radiol. 2013 Jul;23(7):1986-97. doi: 10.1007/s00330-013-2792-3. Epub 2013 Mar 1. Eur Radiol. 2013. PMID: 23455764 Review.
2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck.
Mignion L, Schmitz S, Michoux N, Caignet X, Goebbels RM, Bol A, Neveu MC, Grégoire V, Duprez T, Lhommel R, Amant F, Hermans E, Jordan BF, Machiels JP. Mignion L, et al. Among authors: michoux n. Oncotarget. 2018 Jun 19;9(47):28572-28585. doi: 10.18632/oncotarget.25574. eCollection 2018 Jun 19. Oncotarget. 2018. PMID: 29983881 Free PMC article.
Value of Whole-body Magnetic Resonance Imaging Using the MET-RADS-P Criteria for Assessing the Response to Intensified Androgen Deprivation Therapy in Metastatic Hormone-naïve and Castration-resistant Prostate Cancer.
Van Damme J, Tombal B, Michoux N, Van Nieuwenhove S, Pasoglou V, Triqueneaux P, Padhani AR, Lecouvet FE. Van Damme J, et al. Among authors: michoux n. Eur Urol Oncol. 2024 Nov 5:S2588-9311(24)00238-4. doi: 10.1016/j.euo.2024.10.009. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39505670 Free article.
68 results